Breaking News, Collaborations & Alliances

Evotec, Dewpoint Enter R&D Oncology Alliance

Evotec will facilitate the development of Dewpoint’s oncology assets using its INDiGO platform to de-risk and accelerate the path to clinical testing.

Evotec SE and Dewpoint Therapeutics entered into a strategic R&D collaboration to advance Dewpoint’s lead oncology pipeline programs of condensate modifying therapeutics (c-mods) to Investigational New Drug Applications (INDs) using Evotec’s fully integrated data-driven platform (INDiGO). The partnership brings together Dewpoint’s advanced oncology pipeline programs discovered using its condensate biology and AI` technology platform for identifying modulators of biomolecular condensates w...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters